Search

Search Results
Results 66601 - 66610 of 88302 for cancer
  • New method enables design, production of extremely novel drugs
    News - 24 Jan 2008
    A new chemical synthesis method based on a catalyst worth many times the price of gold and providing a far more efficient and economical method than traditional ones for designing and manufacturing...
  • Pay-for-performance improves patient care
    News - 11 Jan 2008
    A new study examines whether patients seeing physicians participating in a "pay-for-performance" incentive program receive better care than those who saw non-participating physicians.
  • Barr Pharmaceuticals confirms Eloxatin injectable patent challenge
    News - 10 Jan 2008
    Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, has initiated a challenge of the patents listed by Sanofi-Aventis U.S. LLC in connection with its Eloxatin(R)...
  • Oncolytics Biotech announces new reovirus, cyclophosphamide research
    News - 8 Jan 2008
    Oncolytics Biotech Inc. has reported that a research group led by Dr. Richard Vile of the Mayo Clinic College of Medicine in Rochester, Minnesota, published the results of its work testing the...
  • New UIC center to study end-of-life transition
    News - 14 Dec 2007
    The University of Illinois at Chicago College of Nursing has received a federal grant to create a center to study people as they transition to the end of life.
  • First view of synapse in real time
    News - 14 Dec 2007
    For the first time, scientists at Weill Cornell Medical College in New York City have observed in real time a cellular mechanism that's crucial to how brain cells communicate.
  • Odyssey Thera granted U.S. patent for animal imaging
    News - 13 Dec 2007
    Odyssey Thera, Inc. has announced that the United States Patent and Trademark Office granted U.S. Patent No. 7,306,914, entitled "Protein-fragment Complementation Assays (PCA) in whole animals:...
  • SuperGen's CLIMB technology identifies lead Pim kinase inhibitors
    News - 10 Dec 2007
    SuperGen Inc. has announced the presentation of data that describe how its proprietary CLIMB technology was used in lead development and design of small molecule Pim kinase inhibitors (Poster 845,...
  • 60 year mark reached in long-term radiation study
    News - 5 Dec 2007
    For the past 60 years, the National Academies have studied the health effects of radiation exposure in Japanese survivors of the atomic bombs dropped on Hiroshima and Nagasaki, Japan.
  • New way to detect neuropathy
    News - 5 Dec 2007
    Scientists have demonstrated a new technique for detecting a painful nerve condition known as neuropathy, which affects millions of people with diabetes and many other patients as well.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback